Background: Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli are
| Definitions
Healthcare-associated (HA) UTI was defined by the presence of any of the following conditions: Hospitalisation in the past 3 months, nursing home residence or prior antibiotic use in the past 3 months.
Community-acquired UTI was defined when a case of UTI did not meet HA-UTI criteria. 12 Pyelonephritis was diagnosed if a patient had the following symptoms: temperature of 38°C, flank pain or costovertebral angle tenderness or all of these. Sepsis, severe sepsis and septic shock were defined following the criteria of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. 13 Empirical antimicrobial therapy was considered inappropriate when the causative microorganism was reported as nonsusceptible to the antimicrobial agent. 14 
| Microbiological methods
Urine samples were transported from the emergency department to the laboratory of microbiology at University Hospital Dr. Peset and processed following the standard procedures at any time of the day.
For the identification and study of the sensitivity of the isolated organism, a semi-automated system (MicroScan; Beckman Coulter 
What's known
• Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli is a common cause of urinary tract infection (UTI) both in hospital and community settings.
• ESBL-producing E. coli are resistant to most beta-lactams and often co-resistant to other antibiotics.
• Risk factors for ESBL-producing E. coli UTI in elderly patients admitted to hospital so far have not been prospectively studied.
What's new
• Healthcare-associated UTI is a risk factor for ESBLproducing E. coli UTI in elderly patients admitted to hospital.
• 
| Statistical analysis
Categorical variables were compared by using the chi-squared test or Fisher's exact test when appropriate. For the comparison of continuous variables, we used the Student's t test. A P value of <.05 was considered significant. Logistic regression analysis was used to determine independent predictors of ESBL-producing E. coli. All statistical analyses were performed by using the statistical pack SPSS 22.0 (SPSS, Inc., Chicago,IL).
This study was approved by the hospital's Clinical Investigation
Ethics Committee and complies with ethical standards. The
Committee waived the need to obtain informed consent because of the fact that it was a non-interventional study and that all data were kept confidential and information identifying patients were removed. were finally included in the study (see Figure 1 ). All patients included were aged >65 years with community-onset E. coli UTI.
The main demographic and clinical characteristics of the patients are provided in Table 1 . Most of the patients were very old with a mean age of 82.05 ± 7.33 years, two-thirds were older than 80 years, and 64% were women. Just over half of the cases were healthcareassociated UTI and most of the patients had one or more comorbidities. Septic shock was present in 17.4%. 
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Antimicrobial non-susceptibility pattern of E. coli is shown in Table 2 .
Piperacillin tazobactam, gentamicin and imipenem were the only antibiotics which had <20% of non-susceptibility in the total of the series.
Ampicillin-clavulanic acid, cefotaxime and gentamicin had statistically significant differences in percentages of <20% non-susceptibility when the series was analysed according to the presence of ESBL-producing E. coli, healthcare-associated UTI and recurrent urinary infection. Ampicillin, TMP-SMX and ciprofloxacin had percentages of non-susceptibility >20%
for every group of patients analysed, ranging from 20.5% to 100%.
Healthcare-associated UTI was a predictor of ESBL-producing E. coli (OR 6.79, 95% CI 3.22-14.31) by multivariate analysis. However, recurrent urinary infection was not a predictor (OR 1.32, 95% CI 0.70-2.47), see Table 3 . The percentage of ESBL-producing E. coli was 43.9%
in healthcare-associated UTI group and 8.9% in the communityacquired UTI group (P < .001).
| DISCUSSION
In this study, we found that elderly patients admitted to hospital with community-onset E. coli UTI could be classified into two groups according to the presence or not of healthcare-associated criteria with varying risk of infection by ESBL-producing E. coli.
Knowing the risk factors for ESBL-producing E. coli is important in order to choose the appropriate empirical antibiotic therapy in E. coli infections. In this regard, carbapenems have become the antibiotics of choice for therapy of serious ESBL-producing E. coli infections 16, 17 and by contrast other antibiotics, mainly cephalosporins or ß-lactam/ ß-lactamase inhibitors, could be appropriate for non-ESBL-producing E. coli infections. Particularly, in settings where the trimethoprim/sulfamethoxazole and fluoroquinolones resistance rates are higher than 20%.
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T A B L E 2 Antimicrobial non-susceptibility pattern of Escherichia coli isolate from the urine of elderly patients with UTI admitted to the hospital 
